Use of dobesilate for treating ocular haemorrhages
Submacular and vitreous haemorrhage can be successfully treated with a single intravitreal injection of dobesilate without any adverse ocular effects related to treatment. These data support a new promising therapy for the treatment of haemorrhages of the eye.
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Submacular and vitreous haemorrhage can be successfully treated with a single intravitreal injection of dobesilate without any adverse ocular effects related to treatment. These data support a new promising therapy for the treatment of haemorrhages of the eye. |
|---|